SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Börse
ISIN US717081EV18
USD
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081EV18
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.504 News & Informationen zur Pfizer Aktie

  • U.S. coronavirus hospitalizations hit eight-month high over 100,000
    financialpost.com

    U.S. coronavirus hospitalizations hit eight-month high over 100,000

    The number of coronavirus patients in U.S. hospitals breached 100,000 on Thursday, the highest level in eight months, according to the Department of Health and…

  • Honduras to buy 2.7 million more Pfizer COVID-19 vaccine doses
    financialpost.com

    Honduras to buy 2.7 million more Pfizer COVID-19 vaccine doses

    MEXICO CITY — Honduras on Thursday agreed to purchase an additional 2.7 million COVID-19 vaccine doses from drugmaker Pfizer Inc and partner BioNTech to ensure…

  • Pfizer's Covid Technology May Have Cancer Applications
    gurufocus.com

    Pfizer's Covid Technology May Have Cancer Applications

    GuruFocus Article or News written by Barry Cohen and the topic is about: The mRNA-produced vaccines are now being tested in lung and breast cancers

  • Airline Stock Roundup: LUV's Tentative Labor Deal, DAL's Fleet Upgrade & More
    entrepreneur.com

    Airline Stock Roundup: LUV's Tentative Labor Deal, DAL's Fleet Upgrade & More

    Southwest Airlines (LUV) inks a tentative labor deal on its customer-service employees. Delta (DAL) places an order for more A321neo jets.

  • Airline Stocks Have Been Surprisingly Resilient During Health Crisis
    investing.com

    Airline Stocks Have Been Surprisingly Resilient During Health Crisis

    Stocks Analysis by Frank Holmes covering: Pfizer Inc, Brent Oil Futures, Delta Air Lines Inc. Read Frank Holmes's latest article on Investing.com

  • More Companies Weigh Penalizing Employees Without Covid-19 Vaccinations
    online.wsj.com

    More Companies Weigh Penalizing Employees Without Covid-19 Vaccinations

    After months of lobbying and encouragement, businesses are considering more forceful methods to get workers vaccinated against Covid-19, such as Delta’s benefit surcharge.

  • Airline Stocks Have Been Surprisingly Resilient During The Health Crisis
    forbes.com

    Airline Stocks Have Been Surprisingly Resilient During The Health Crisis

    The highly transmissible delta variant of Covid-19 has stalled the recovery of commercial air travel and weakened bookings in July and August, which have traditionally been among airlines’ busiest months of the year.

  • Pfizer (PFE), BioNTech Seek Full Approval for COVID Jab Booster
    zacks.com

    Pfizer (PFE), BioNTech Seek Full Approval for COVID Jab Booster

    The booster dose of Pfizer (PFE)/BioNTech's (BNTX) mRNA-based COVID-19 vaccine, Comirnaty dose induced significant SARS-CoV-2 neutralizing antibody titers in phase III study.

  • BioNTech- und Pfizer-Aktien in Rot: BioNTech und Pfizer reichen weitere Daten zu Auffrischungsimpfung ein - Impfstoff für Lateinamerika
    finanzen.net

    BioNTech- und Pfizer-Aktien in Rot: BioNTech und Pfizer reichen weitere Daten zu Auffrischungsimpfung ein – Impfstoff für Lateinamerika

    Das deutsche Unternehmen BioNTech und sein US-Partner Pfizer wollen weitere Daten für die Zulassung einer Auffrischungsimpfung gegen das Coronavirus bei der US-Arzneimittelbehörde FDA einreichen. 26.08.2021

  • Advent Said to Weigh Purchase of Swedish Biotech Firm Sobi
    bloombergquint.com

    Advent Said to Weigh Purchase of Swedish Biotech Firm Sobi

    (Bloomberg) — Private equity firm Advent International is considering a potential purchase of drugmaker Swedish Orphan Biovitrum AB, people with knowledge of the matter said.

  • Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now
    marijuanastocks.com

    Best Medical Marijuana Stocks To Buy In 2021? 2 Possible Long Term Investments Right Now

    Could These Be Good Long Term Investments For Your Portfolio?

  • Japan Suspends 1.63M Doses Of Moderna Over Contamination
    businessworld.in

    Japan Suspends 1.63M Doses Of Moderna Over Contamination

    The health ministry said contamination was reported from multiple vaccination sites. Some doses might have been administered, but no adverse health effects have been reported so far, , Moderna, japan, supply shortage, Covid 19, health ministry

  • U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January
    marketwatch.com

    U.S. COVID-19 hospitalizations hit 100,000 to mark highest level since January

    The number of COVID-19 hospitalizations in the U.S. has been slowly ticking up, and new data shows that 100,000 people are currently hospitalized with…

  • BioNTech’s Capabilities Questionable, Despite Vaccine Victory By TipRanks
    investing.com

    BioNTech’s Capabilities Questionable, Despite Vaccine Victory By TipRanks

    BioNTech’s Capabilities Questionable, Despite Vaccine Victory

  • After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?
    forbes.com

    After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?

    The stock price of Pfizer reached an all-time high of $52 last week before a recent sell-off in Covid-19 vaccine stocks drove PFE down to its current level of around $48. PFE stock has fallen 4% over the last five days. The decline was seen in other Covid-19 vaccine stocks as well…

  • Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America
    livemint.com

    Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America

    Deal would allow Brazil’s Eurofarma to produce at least 100 million doses annually for distribution in the region

  • Pfizer Announces New Chief Business Innovation Officer
    news.google.com

    Pfizer Announces New Chief Business Innovation Officer

    Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive Vice President and Chief Business Innovation Officer. Mr. Malik will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Albert Bourla. Mr. Malik joins Pfizer from McKinsey & Company, where he most recently served as the Managing Partner responsible for the firm’s U.S. operations. Previously, he led the firm’s Global Pharmaceuticals & Medical Products practice. Mr. Malik succeeds John Young, Executive Vice President and Chief Business Officer, who recently announced his intent to retire after a 34-year career at Pfizer. Mr. Malik begins his role on August 30, 2021 and will work with John to ensure a seamless transition. At Pfizer, Mr. Malik will oversee the company’s strategy, business development, portfolio management, pipeline prioritization, and formation of new business ventures, as well as the advancement of innovative access

  • Illinois governor to announce mask mandate, order vaccines for schools
    investing.com

    Illinois governor to announce mask mandate, order vaccines for schools

    Illinois governor to announce mask mandate, order vaccines for schools – reports

  • Crude oil prices decline on fuel demand worries; WTI trades below $68 a barrel
    moneycontrol.com

    Crude oil prices decline on fuel demand worries; WTI trades below $68 a barrel

    Crude oil prices are expected to trade sideways to up for the day with resistance at $69 and support at $65 per barrel.

  • Politicians getting third Covid jab as most Indonesians unvaccinated
    businessmirror.com.ph

    Politicians getting third Covid jab as most Indonesians unvaccinated

    Political elites in Indonesia are admitting to getting a third dose of Covid-19 vaccines, defying calls from the health ministry as most of the country have not received even their first shot. Military Chief Hadi Tjahjanto and East Kalimantan Governor Isran Noor said during a meeting with President Joko Widodo…

  • Pfizer, BioNTech sign LOI with Brazil's Eurofarma to make COVID-19 vaccines for use in Latin America
    marketwatch.com

    Pfizer, BioNTech sign LOI with Brazil's Eurofarma to make COVID-19 vaccines for use in Latin America

    Pfizer Inc. undefined and BioNTech SE undefined said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company…

  • Protalix BioTherapeutics Announces Closing of Private Note Exchange
    prnewswire.com

    Protalix BioTherapeutics Announces Closing of Private Note Exchange

    /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and…

  • 10 Stocks With Strong Media Sentiment In August 2021
    investing.com

    10 Stocks With Strong Media Sentiment In August 2021

    Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Microsoft Corporation, Walt Disney Company, Apple Inc, Pfizer Inc. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com

  • Netflix, Pfizer, Coinbase, Pinduoduo, JD, Meituan — These Are Cathie Wood's Key Trades From Wednesday
    markets.businessinsider.com

    Netflix, Pfizer, Coinbase, Pinduoduo, JD, Meituan — These Are Cathie Wood's Key Trades From Wednesday

    Cathie Wood-led Ark Invest on Wednesday trimmed all of its exposure to Netflix Inc (NASDAQ:NFLX) in one of the two active exchange-trade…

  • Professional Acne Treatment Market Worth $13,124.5 Million by 2030 says P&S Intelligence
    prnewswire.com

    Professional Acne Treatment Market Worth $13,124.5 Million by 2030 says P&S Intelligence

    /PRNewswire/ — From $6,298.9 million in 2020, the global professional acne treatment market value is predicted to reach $13,124.5 million by 2030, at a 7.6%…

  • Dollar Edges Higher; Powell's Speech Seen "Litmus Test"
    investing.com

  • Japan halts some Moderna vaccine after contamination found
    thehindubusinessline.com

    Japan halts some Moderna vaccine after contamination found

    Some doses might have been administered, but no adverse health effects have been reported so far, officials said

  • Reopening Trade Takes Hold
    investing.com

    Reopening Trade Takes Hold

    Forex Analysis by Ashraf Laidi covering: GBP/USD, USD/JPY, AUD/USD, USD/CAD. Read Ashraf Laidi's latest article on Investing.com

  • Did FDA Really Approve the Pfizer Covid Vaccine? Wait. What?
    lewrockwell.com

  • Cathie Wood’s ARK Invest Buys for 8
    247wallst.com

  • Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease By Investing.com
    investing.com

    Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease By Investing.com

    Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease

  • Taiwan says BioNTech shots available earlier than expected
    financialpost.com

    Taiwan says BioNTech shots available earlier than expected

    TAIPEI — Taiwan’s government said BioNTech SE COVID-19 vaccines are available earlier than expected and it is striving to obtain them in competition with other…

  • S&P 500, Nasdaq notch all-time closing highs ahead of Jackson Hole
    moneycontrol.com

    S&P 500, Nasdaq notch all-time closing highs ahead of Jackson Hole

    The Dow Jones Industrial Average rose 39.24 points, or 0.11%, to 35,405.5, the S&P 500 gained 9.96 points, or 0.22%, to 4,496.19 and the Nasdaq Composite added 22.06 points, or 0.15%, to 15,041.86.

  • Pfizer Seeks FDA Approval For COVID-19 Vaccine Booster
    markets.businessinsider.com

    Pfizer Seeks FDA Approval For COVID-19 Vaccine Booster

    (RTTNews) – Pfizer Inc. (PFE) is seeking an approval from the U.S. Food and Drug Administration for its booster dose of COVID-19 vaccine. Pfizer …

  • U.S. likely to approve COVID-19 boosters at 6 months after vaccination
    marketwatch.com

    U.S. likely to approve COVID-19 boosters at 6 months after vaccination

    Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the…

  • S&P 500, Nasdaq notch all-time closing highs ahead of Jackson Hole
    theedgemarkets.com

    S&P 500, Nasdaq notch all-time closing highs ahead of Jackson Hole

    Wall Street gained ground again on Wednesday, with chipmakers and financials helping to push the S&P 500 and the Nasdaq to record closing highs as investors look to the upcoming Jackson Hole Symposium for assurances that Federal Reserve's timeline for policy tightening remains intact. With few negative catalysts to sour the risk-on sentiment, all three major U.S. indexes ended the session modestly higher.

  • U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
    financialpost.com

    U.S. plans COVID-19 booster shots at six months instead of eight – WSJ

    U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced…

  • Heart inflammation risk boosted slightly by vaccine, more by COVID-19
    investing.com

    Heart inflammation risk boosted slightly by vaccine, more by COVID-19

    Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study

  • Outlook On The Multiple Myeloma Drugs Global Market To 2026 - By Therapy, Drug Type, End-user, Distribution Channel And Region
    thestreet.com

    Outlook On The Multiple Myeloma Drugs Global Market To 2026 – By Therapy, Drug Type, End-user, Distribution Channel And Region

    DUBLIN, Aug. 25, 2021 /PRNewswire/ — The “Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • U.S. set to approve COVID-19 booster shots at six months: WSJ
    economiccollapsenews.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba